American Well Co. (NYSE:AMWL) Receives Consensus Rating of "Hold" from Brokerages

American Well Co. (NYSE:AMWL - Get Free Report) has been assigned an average recommendation of "Hold" from the six ratings firms that are presently covering the stock, MarketBeat.com reports. Five equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $11.90.

Several equities research analysts have recently weighed in on the company. Wells Fargo & Company upgraded American Well from an "equal weight" rating to an "overweight" rating and set a $15.00 price target on the stock in a report on Monday, January 13th. Truist Financial increased their target price on American Well from $10.00 to $12.00 and gave the stock a "hold" rating in a research note on Friday. Needham & Company LLC reissued a "hold" rating on shares of American Well in a research note on Thursday, February 13th. Stifel Nicolaus upped their price target on shares of American Well from $9.00 to $10.00 and gave the stock a "hold" rating in a report on Thursday, February 13th. Finally, Morgan Stanley decreased their price objective on shares of American Well from $20.00 to $10.50 and set an "equal weight" rating for the company in a report on Tuesday, December 17th.

Institutional Trading of American Well

Several institutional investors and hedge funds have recently made changes to their positions in the company. Geode Capital Management LLC increased its position in American Well by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 147,925 shares of the company's stock valued at $1,073,000 after purchasing an additional 922 shares during the period. Northern Trust Corp increased its holdings in American Well by 7.4% during the fourth quarter. Northern Trust Corp now owns 29,021 shares of the company's stock valued at $210,000 after buying an additional 1,992 shares during the period. Two Sigma Investments LP raised its stake in American Well by 12.3% in the fourth quarter. Two Sigma Investments LP now owns 19,216 shares of the company's stock worth $139,000 after buying an additional 2,102 shares in the last quarter. Jane Street Group LLC lifted its holdings in American Well by 21.9% during the fourth quarter. Jane Street Group LLC now owns 19,260 shares of the company's stock worth $140,000 after buying an additional 3,462 shares during the period. Finally, Compagnie Lombard Odier SCmA bought a new stake in American Well during the 4th quarter valued at $45,000. 56.05% of the stock is currently owned by institutional investors.

American Well Stock Down 2.8 %

AMWL traded down $0.34 during trading on Friday, reaching $11.83. The company had a trading volume of 178,430 shares, compared to its average volume of 72,795. The business has a 50 day simple moving average of $9.41 and a 200-day simple moving average of $9.19. The stock has a market cap of $181.16 million, a P/E ratio of -0.81 and a beta of 1.18. American Well has a 52 week low of $5.00 and a 52 week high of $26.40.

American Well (NYSE:AMWL - Get Free Report) last released its quarterly earnings results on Wednesday, February 12th. The company reported ($2.77) EPS for the quarter, topping analysts' consensus estimates of ($3.04) by $0.27. American Well had a negative net margin of 84.27% and a negative return on equity of 52.49%. As a group, equities research analysts expect that American Well will post -13.38 EPS for the current fiscal year.

About American Well

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.